Special offer for AMSA India students on UpToDate!

UpToDate and AMSA India have collaborated to offer AMSA students a special rate on personal subscriptions to UpToDate®.
Subscribe today
Thanks to our new partnership, AMSA India student members can save 50% on a personal annual or longer subscription to UpToDate!*

UpToDate is the premier evidence-based clinical decision support resource for students that can help you find the answers you need when studying for tests, writing papers, or looking for answers to difficult medical questions. Plus, as an AMSA member you can save on a personal subscription to UpToDate.

With a personal subscription to UpToDate you can:
  • Access more than 12,300 clinical topics in over 25 specialties from your computer, smartphone, or tablet with our mobile app.
  • Keep up with the latest updates in your field with “What’s New” and “Practice Changing UpDates”; including information on COVID-19 that is continuously updated.
  • View laboratory monographs and accompanying algorithms to help you quickly interpret abnormal test results and choose next steps, along with interactive, evidence-based pathways to help you address specific clinical questions and provide more personalized care.
  • Increase medication safety with select monographs and interactive tools from our included drug reference, UpToDate® Lexidrug.

Prices are subject to change without notice. Taxes are additional.  

*Savings on annual and longer subscriptions only and based on subscription type. AMSA India member prices are reflected in the UpToDate AMSA India storefront. Applicable taxes may apply. Proof of student status is required to receive trainee pricing. 

Access to UpToDate mobile app requires an individual subscription. For current information on supported devices, please visit www.uptodate.com/mobile.

UpToDate Pathways and UpToDate Lab Interpretation are included in all newly purchased individual UpToDate Online subscriptions and will be available when the new subscription begins.


© {{CurrentYear}} UpToDate, Inc., and its affiliates and/or licensors. All rights reserved.